Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Learn what can go wrong with a bond ladder and how to prevent issues. Identify warning signs and practical fixes to stay on course.
27,765 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Bitwise’s Q2 2026 review shows a third straight down quarter for its Large Cap Crypto Index, yet on-chain activity an...
In 2026, property owners are selling experiences, not just space. Lenders are adjusting terms as tenants sign leases ...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...
A Utah-based defamation suit accuses Kevin O’Leary and Fox News of tying two local political groups to the CCP amid o...
Apple’s 2026 strategy centers on Services and cash returns, contrasting with Amazon’s AI infrastructure push, shaping...
Tokenized shares backed by real company stock are moving across borders. Learn how kraken parent company makes this p...
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
New GDP figures show fourth-quarter growth remained positive but cooled, challenging the notion of a looming slowdown...
XRP nears a fifth straight red monthly candle, a pattern last seen in 2016-2017. Traders weigh whether history could ...